DK0983273T3 - Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler - Google Patents
Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midlerInfo
- Publication number
- DK0983273T3 DK0983273T3 DK98921294T DK98921294T DK0983273T3 DK 0983273 T3 DK0983273 T3 DK 0983273T3 DK 98921294 T DK98921294 T DK 98921294T DK 98921294 T DK98921294 T DK 98921294T DK 0983273 T3 DK0983273 T3 DK 0983273T3
- Authority
- DK
- Denmark
- Prior art keywords
- ethylene glycol
- glycol esters
- photoactive agents
- monohydrobenzoporphyrin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85249497A | 1997-05-07 | 1997-05-07 | |
PCT/CA1998/000468 WO1998050387A1 (en) | 1997-05-07 | 1998-05-06 | Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0983273T3 true DK0983273T3 (da) | 2002-04-22 |
Family
ID=25313492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98921294T DK0983273T3 (da) | 1997-05-07 | 1998-05-06 | Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler |
Country Status (21)
Country | Link |
---|---|
US (2) | US5929105A (pl) |
EP (2) | EP0983273B8 (pl) |
JP (1) | JP3378889B2 (pl) |
KR (1) | KR100397131B1 (pl) |
CN (1) | CN1113882C (pl) |
AR (1) | AR012673A1 (pl) |
AT (1) | ATE211473T1 (pl) |
AU (1) | AU741070B2 (pl) |
CA (1) | CA2284879C (pl) |
CZ (1) | CZ294715B6 (pl) |
DE (1) | DE69803376T2 (pl) |
DK (1) | DK0983273T3 (pl) |
ES (2) | ES2437790T3 (pl) |
HK (1) | HK1042439B (pl) |
HU (1) | HU221754B1 (pl) |
IL (1) | IL132066A (pl) |
NO (1) | NO314264B1 (pl) |
NZ (1) | NZ338031A (pl) |
PL (1) | PL202341B1 (pl) |
PT (1) | PT983273E (pl) |
WO (1) | WO1998050387A1 (pl) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6756396B1 (en) * | 1997-05-07 | 2004-06-29 | Qlt Inc. | Ethylene glycol esters as photoactive agents |
US6364907B1 (en) | 1998-10-09 | 2002-04-02 | Qlt Inc. | Method to prevent xenograft transplant rejection |
US6331235B1 (en) * | 1998-12-11 | 2001-12-18 | The University Of British Columbia | Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis |
US6344050B1 (en) | 1998-12-21 | 2002-02-05 | Light Sciences Corporation | Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue |
US6602274B1 (en) * | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
AU2412800A (en) * | 1999-01-15 | 2000-08-01 | Light Sciences Corporation | Noninvasive vascular therapy |
AU2789900A (en) * | 1999-02-26 | 2000-09-21 | Qlt Phototherapeutics, Inc. | Photodynamic therapy in combination with apoptosis inducing factors |
GB9905911D0 (en) | 1999-03-15 | 1999-05-05 | Photocure As | Method |
US6609014B1 (en) | 1999-04-14 | 2003-08-19 | Qlt Inc. | Use of PDT to inhibit intimal hyperplasia |
US20020022032A1 (en) * | 1999-04-23 | 2002-02-21 | Curry Patrick Mark | Immuno-adjuvant PDT treatment of metastatic tumors |
US20040208855A1 (en) * | 1999-11-17 | 2004-10-21 | Allison Beth Anne | Use of PDT to inhibit intimal hyperplasia |
US7122568B1 (en) | 1999-11-17 | 2006-10-17 | Qlt, Inc. | Use of low-dose PDT to inhibit restenosis |
JP2003519670A (ja) * | 2000-01-12 | 2003-06-24 | ライト サイエンシーズ コーポレイション | 眼疾患の新規処置 |
AU2001258095A1 (en) * | 2000-05-08 | 2001-11-20 | The University Of British Columbia | Drug delivery systems for photodynamic therapy |
CA2408332C (en) | 2000-05-08 | 2011-02-15 | The University Of British Columbia | Supports for photosensitizer formulations |
DK1339862T3 (en) * | 2000-11-29 | 2014-02-17 | Pci Biotech As | PHOTO CHEMICAL INTERNALISATION VIRUS-MEDIATED MOLECULAR-DELIVERY INTO cytosol |
AU2085302A (en) * | 2000-11-29 | 2002-06-11 | Norwegian Radium Hospital Res | Photochemical internalization for delivery of molecules into the cytosol |
US6984395B2 (en) * | 2001-04-11 | 2006-01-10 | Qlt, Inc. | Drug delivery system for hydrophobic drugs |
CA2448562A1 (en) * | 2001-05-31 | 2002-12-05 | Miravant Pharmaceuticals, Inc. | Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
WO2003017846A1 (en) * | 2001-08-22 | 2003-03-06 | Montana State University-Bozeman | Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy |
US20040013717A1 (en) * | 2001-11-02 | 2004-01-22 | Allen Theresa Mary | PEG-lipid containing formulations |
US7264629B2 (en) | 2001-11-09 | 2007-09-04 | Qlt, Inc. | Photodynamic therapy for the treatment of hair loss |
DE60225169D1 (de) * | 2001-11-09 | 2008-04-03 | Quadra Logic Tech Inc | Photodynamische therapie zur behandlung von haarausfall |
CA2437638A1 (en) * | 2003-08-20 | 2005-02-20 | John Robert North | Photodynamic therapy |
CA2457214A1 (en) | 2004-02-06 | 2005-08-06 | Qlt Inc. | Photodynamic therapy for the treatment of acne |
US20120034157A1 (en) * | 2010-08-03 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Artificial cells |
CN105017187B (zh) | 2009-07-08 | 2017-10-24 | 德米拉(加拿大)公司 | 用于治疗皮肤病症或疾病状态的tofa类似物 |
PL2531206T3 (pl) | 2010-02-04 | 2017-12-29 | Morphotek, Inc. | Polipeptydy i koniugaty chlorotoksyny i ich zastosowanie |
CA2824768A1 (en) | 2011-01-13 | 2012-07-19 | Qlt Inc. | Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof |
WO2013003507A1 (en) | 2011-06-27 | 2013-01-03 | Morphotek, Inc. | Multifunctional agents |
EP2771688B1 (en) | 2011-10-25 | 2018-09-26 | Memorial Sloan-Kettering Cancer Center | Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer |
AU2013290140A1 (en) | 2012-07-11 | 2015-01-29 | Dermira, Inc. | Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof |
CA2889756C (en) | 2012-10-26 | 2023-03-14 | Memorial Sloan-Kettering Cancer Center | Thiohydantoin compounds as androgen receptor modulators |
CA3142856A1 (en) | 2013-12-23 | 2015-07-02 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for treating cancer using peptide nucleic acid-based agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5171749A (en) | 1987-01-20 | 1992-12-15 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US5095030A (en) * | 1987-01-20 | 1992-03-10 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US5283255A (en) * | 1987-01-20 | 1994-02-01 | The University Of British Columbia | Wavelength-specific cytotoxic agents |
US4920143A (en) * | 1987-04-23 | 1990-04-24 | University Of British Columbia | Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents |
US4883790A (en) | 1987-01-20 | 1989-11-28 | University Of British Columbia | Wavelength-specific cytotoxic agents |
EP0476011A1 (en) * | 1989-06-07 | 1992-03-25 | The University Of British Columbia | Photosensitizing diels-alder porphyrin derivatives |
US5498710A (en) * | 1994-04-22 | 1996-03-12 | Health Research, Inc. | Alkyl ether analogues of benzoporphyrin derivatives |
PT983272E (pt) * | 1997-05-07 | 2004-03-31 | Univ British Columbia | Nova classe de compostos fotoactivos derivados de benzoporfirina |
-
1998
- 1998-05-06 AU AU74207/98A patent/AU741070B2/en not_active Ceased
- 1998-05-06 AT AT98921294T patent/ATE211473T1/de active
- 1998-05-06 PT PT98921294T patent/PT983273E/pt unknown
- 1998-05-06 EP EP98921294A patent/EP0983273B8/en not_active Expired - Lifetime
- 1998-05-06 IL IL132066A patent/IL132066A/en not_active IP Right Cessation
- 1998-05-06 HU HU0003604A patent/HU221754B1/hu not_active IP Right Cessation
- 1998-05-06 ES ES01121719.7T patent/ES2437790T3/es not_active Expired - Lifetime
- 1998-05-06 WO PCT/CA1998/000468 patent/WO1998050387A1/en active IP Right Grant
- 1998-05-06 EP EP01121719.7A patent/EP1177795B1/en not_active Expired - Lifetime
- 1998-05-06 PL PL336790A patent/PL202341B1/pl unknown
- 1998-05-06 CN CN98804737A patent/CN1113882C/zh not_active Expired - Fee Related
- 1998-05-06 NZ NZ338031A patent/NZ338031A/en not_active IP Right Cessation
- 1998-05-06 JP JP54758598A patent/JP3378889B2/ja not_active Expired - Fee Related
- 1998-05-06 DK DK98921294T patent/DK0983273T3/da active
- 1998-05-06 CZ CZ19993923A patent/CZ294715B6/cs not_active IP Right Cessation
- 1998-05-06 ES ES98921294T patent/ES2171022T3/es not_active Expired - Lifetime
- 1998-05-06 KR KR10-1999-7010283A patent/KR100397131B1/ko not_active IP Right Cessation
- 1998-05-06 CA CA002284879A patent/CA2284879C/en not_active Expired - Fee Related
- 1998-05-06 DE DE69803376T patent/DE69803376T2/de not_active Expired - Lifetime
- 1998-05-07 AR ARP980102133A patent/AR012673A1/es active IP Right Grant
- 1998-06-01 US US09/088,524 patent/US5929105A/en not_active Expired - Lifetime
-
1999
- 1999-05-17 US US09/313,106 patent/US6153639A/en not_active Expired - Lifetime
- 1999-11-05 NO NO19995436A patent/NO314264B1/no not_active IP Right Cessation
-
2002
- 2002-06-05 HK HK02104249.9A patent/HK1042439B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0983273T3 (da) | Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler | |
NO20014412D0 (no) | Forbindelser nyttige som anti-inflammatoriske midler | |
NO20002173L (no) | Pleuromutilin-derivater som antimikrobielle midler | |
NO20013559D0 (no) | Aromatiske heterocykliske forbindelser som anti- inflammatoriske midler | |
NO20013671D0 (no) | Substituerte bicycliske derivater nyttige som anticancer midler | |
NO20002217D0 (no) | Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler | |
NO992725D0 (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
FI951001A (fi) | Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina | |
NO971137L (no) | Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser | |
NO990435L (no) | Fremstilling av estere som overflateaktive midler | |
NO20021251D0 (no) | Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister | |
NO972887D0 (no) | Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel | |
DK0964863T3 (da) | Oxazolidinoner som 5-HT2A-antagonister | |
NO20020457L (no) | Benzenaminderivater som antikoagulanter | |
DK1075471T3 (da) | Idolylderivater som serotonerge midler | |
NO20001200D0 (no) | Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase | |
FI970727A0 (fi) | Foerfarande och anordning foer torkning av objekt som innehaoller vatten | |
NO996244D0 (no) | Pyrrolidinkarboksylsyrederivater som endotelinantagonister | |
NO20002321D0 (no) | Bifenylderivater som farmasøytiske midler | |
FI972585A0 (fi) | Virustenvastaisina aineina käyttökelpoiset tienoksatsinonijohdannaiset | |
FI980557A0 (fi) | Foerfarande vid kalandrering av pappersbana och kalander som tillaempar foerfarandet | |
EE200000239A (et) | Uued metüleenbisfosfoonhappe derivaadid | |
FI990032A0 (fi) | Okulaarisia hypotensiivisiä aktiivisia yhdisteitä | |
DK1216249T3 (da) | Usubstituerede ethyl- og propylderivater af phenoxythienoisoxazoler som D4-antagonister | |
DK1380585T3 (da) | Pyrazolopyridinon som mellemprodukt |